Kyproula Christodoulou

Prof. Kyproula Christodoulou

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AAAnthony Antonellis
Anthony Antonellis
RERachel E. Ellsworth
Rachel E. Ellsworth
NSNyamkhishig Sambuughin
Nyamkhishig Sambuughin
IPImke Puls
Imke Puls
AAAnnette Abel
Annette Abel
EGEric D. Green
Eric D. Green

1 May 2000 in Nature Genetics
Verified
Journal Article
Closed access
ABAlessandra Bolino
Alessandra Bolino
MMMaria Muglia
Maria Muglia
FCFrancesca Luisa Conforti
Francesca Luisa Conforti
ELEric LeGuern
Eric LeGuern
MSMustafa Salih
Mustafa Salih
AMAnthony P. Monaco
Anthony P. Monaco

13 July 2005 in Brain
Verified
Journal Article
Open access
PDF file
KSKumaraswamy Sivakumar
Kumaraswamy Sivakumar
TKTheodoros Kyriakides
Theodoros Kyriakides
IPImke Puls
Imke Puls
GNGarth A. Nicholson
Garth A. Nicholson
BFBenoît Funalot
Benoît Funalot
LGLev G. Goldfarb
Lev G. Goldfarb
We describe clinical, electrophysiological, histopathological and molecular features of a unique disease caused by mutations in the glycyl-tRNA synthetase (GARS) gene. Sixty patients from five multigenerational families have been evaluated. The disease is characterized by adolescent onset of weakness, and atrophy of thenar and first dorsal interosseus muscles progressing to involve foot and peroneal muscles in most but not all cases. Mild to moderate sensory deficits develop in a minority of patients. Neurophysiologically confirmed chronic denervation in distal muscles with reduced compound motor action potentials were features consistent with both motor neuronal and axonal pathology. Sural nerve biopsy showed mild to moderate selective loss of small- and medium-sized myelinated and small unmyelinated axons, although sensory nerve action potentials were not significantly decreased. Based on the presence or absence of sensory changes, the disease phenotype was initially defined as distal spinal muscular atrophy type V (dSMA-V) in three families, Charcot-Marie-Tooth disease type 2D (CMT2D) in a single family, and as either dSMA-V or CMT2D in patients of another large family. Linkage to chromosome 7p15 and the presence of disease-associated heterozygous GARS mutations have been identified in patients from each of the five studied families. We conclude that patients with GARS mutations present a clinical continuum of predominantly motor distal neuronopathy/axonopathy with mild to moderate sensory involvement that varies between the families and between members of the same family. Awareness of these overlapping clinical phenotypes associated with mutations in GARS will facilitate identification of this disorder in additional families and direct future research toward better understanding of its pathogenesis.

1 May 1998 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
KCKyproula Christodoulou
Kyproula Christodoulou
MTMarios Tsingis
Marios Tsingis
CSChristoforos Stavrou
Christoforos Stavrou
AEAndri Eleftheriou
Andri Eleftheriou
PPPetros Papapavlou
Petros Papapavlou
Constantinos DeltasConstantinos Deltas
Constantinos Deltas
There is a group of inherited cystic nephropathies that are characterized by juvenile onset recessive inheritance (familial juvenile nephronophthisis, FJN) or by adult onset dominant inheritance (medullary cystic disease, MCD) and share similar clinico-pathological presentation to the extent that they are usually grouped together under the term FJN/MCD complex. The main symptoms consist of renal cyst formation in the medulla or the corticomedullary junction and salt wasting. Although earlier reports had suggested that one single gene may be responsible for this pathology, recent reports have shown that the FJN complex itself comprises a genetically heterogeneous group. Here we are presenting two large Cypriot families that segregate autosomal dominant medullary cystic kidney disease (ADMCKD) with hyperuricemia and gout and with very late age of onset (mean 62.2 and 51.5 years). We performed DNA linkage mapping using highly polymorphic microsatellite markers and found linkage to marker locus D1S1595 at 1q21 with a two-point lod score of 6.45 at Θ = 0.00. Analysis of haplotypes and of critical recombinants enabled confinement of the disease locus within an ∼8 cM region between marker loci D1S498 and D1S2125. FISH mapping with a large P1 clone confirmed the physical localization within 1q21. The two families share the same disease haplotype, thus suggesting their relationship through a common ancestor and the possible existence of a single ADMCKD-causing mutation within these families. To our knowledge this is the first genetic locus identified to cause FJN/MCD pathology of the dominant adult type.

1 October 2002 in neurogenetics
Verified
Journal Article
Closed access
PDF file
DGDomna-Maria Georgiou
Domna-Maria Georgiou
JZJanez Zidar
Janez Zidar
MKMarko Korošec
Marko Korošec
LMLefkos T. Middleton
Lefkos T. Middleton
TKTheodoros Kyriakides
Theodoros Kyriakides
KCKyproula Christodoulou
Kyproula Christodoulou

11 February 2020 in Oncotarget
Verified
Journal Article
Open access
PDF file
LKLola Koniali
Lola Koniali
AHAndreas Hadjisavvas
Andreas Hadjisavvas
ACAnastasia Constantinidou
Anastasia Constantinidou
KCKyproula Christodoulou
Kyproula Christodoulou
YCYiolanda Christou
Yiolanda Christou
KKKyriacos Kyriacou
Kyriacos Kyriacou
Https://doi.org/10.18632/oncotarget.27453 Lola Koniali, Andreas Hadjisavvas, Anastasia Constantinidou, Kyproula Christodoulou, Yiolanda Christou, Christiana Demetriou, Andreas S. Panayides,...